0001181431-12-010793.txt : 20120222
0001181431-12-010793.hdr.sgml : 20120222
20120222160551
ACCESSION NUMBER: 0001181431-12-010793
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120221
FILED AS OF DATE: 20120222
DATE AS OF CHANGE: 20120222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Slichenmyer William
CENTRAL INDEX KEY: 0001486428
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34655
FILM NUMBER: 12630350
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001325879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6172995000
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
rrd335326.xml
SLICHENMYER FORM 4
X0304
4
2012-02-21
0
0001325879
AVEO PHARMACEUTICALS INC
AVEO
0001486428
Slichenmyer William
C/O AVEO PHARMACEUTICALS, INC.
75 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Common Stock
2012-02-21
4
M
0
2000
9.64
A
25693
D
Common Stock
2012-02-21
4
S
0
2000
13.6651
D
23693
D
Stock Option (right to buy)
9.64
2012-02-21
4
M
0
2000
0
D
2019-10-08
Common Stock
2000
116500
D
The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.55 to $13.78, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The option vested as to 25% of the shares on September 14, 2010 and thereafter vests in equal monthly installments as to the remaining shares through September 14, 2013.
/s/ Joseph D. Vittiglio, attorney-in-fact
2012-02-22